Journal article

The contributions of First Nations ethnicity, income, and delays in surgery on mortality post-fracture: a population-based analysis

WD Leslie, SL Brennan, HJ Prior, LM Lix, C Metge, B Elias

OSTEOPOROSIS INTERNATIONAL | SPRINGER LONDON LTD | Published : 2013

University of Melbourne Researchers

Grants

Awarded by Manitoba Centre for Health Policy


Awarded by Canadian Institutes of Health Research (CIHR)


Awarded by National Health and Medical Research Council (NHMRC) of Australia


Funding Acknowledgements

The authors acknowledge the Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository (HIPC project 2000/2001-08). The authors are indebted to the First Nations and Inuit Health Branch, and Aboriginal Affairs and Northern Development Canada, for permission to use the Status Verification System, and to the Health Information Research Committee of the Assembly of Manitoba Chiefs for actively supporting this work. The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, the Assembly of Manitoba Chiefs, or other data providers is intended, or should be inferred. This article has been reviewed and approved by the members of the Manitoba Bone Density Program Committee.This research was funded through an operating grant (ACB-65731) from the Canadian Institutes of Health Research (CIHR). Sharon L. Brennan was funded by a National Health and Medical Research Council (NHMRC) of Australia Early Career Fellowship (no. 1012472). Lisa M Lix was funded by a University of Saskatchewan Centennial Chairs Program.William D. Leslie received research grants from Merck Frosst Canada, Amgen Pharmaceuticals Canada, and Genzyme Canada; research honoraria and educational grants from Sanofi-Aventis, Procter & Gamble Pharmaceuticals Canada, and Novartis; and has involvement with Advisory Boards for Genzyme Canada, Novartis, and Amgen Pharmaceuticals Canada. Lisa M. Lix and Colleen Metge received research grant from Amgen Pharmaceuticals Canada. All other authors declare no competing interests.